CLOV vs DRS
Clover Health Investments Corp (CLOV) versus Leonardo DRS, Inc. Common Stock (DRS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Leonardo DRS, Inc. Common Stock (DRS) is a aerospace & defense company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DRS revenue for 2024-12-31 was $3.23B. Net income was $213.0M. Revenue was up 14.4% from 2023-12-31 to 2024-12-31. DRS currently screens at market cap $12.31B and trailing P/E 43.1.
CLOV currently screens at market cap $1.55B. DRS currently screens at market cap $12.31B and trailing P/E 43.1.
Not investment advice. Open the CLOV and DRS stock pages for the full models.
Not investment advice.